Concepedia

Herriot Tabuteau

HT

Statistics

Publications

4

Citations

357

H-Index

4

Active since

1995

Affiliations

Yale University(Current)

Herriot Tabuteau is an author at Yale University specializing in psychiatry, antidepressant pharmacology, and neuroscience.

Publications per year

1995–2022

4

Publications

4

Effect of AXS-05 (Dextromethorphan-Bupropion) in Major Depressive Disorder: A Randomized Double-Blind Controlled Trial

Herriot Tabuteau, Amanda Jones, Ashley Anderson et al. · American Journal of Psychiatry · 2022 · 133 citations

, , +17

Efficacy and Safety of AXS-05 (Dextromethorphan-Bupropion) in Patients With Major Depressive Disorder

Dan V. Iosifescu, Amanda Jones, Cedric O’Gorman et al. · The Journal of Clinical Psychiatry · 2022 · 127 citations · Full text

, , +17

Dynorphin and the kappa 1 ligand [3H]U69,593 binding in the human epileptogenic hippocampus

Nihal C. de Lanerolle, Anne Williamson, C. N. Meredith et al. · Epilepsy Research · 1997 · 57 citations · Full text

, , +17

Regional Distributions of Hippocampal Na<sup>+</sup>, K<sup>+</sup>‐ATPase, Cytochrome Oxidase, and Total Protein in Temporal Lobe Epilepsy

Michael Brines, Herriot Tabuteau, S. Sundaresan et al. · Epilepsia · 1995 · 40 citations

, , +17

1–4 of 4